FGHQF
Price
$0.10
Change
-$0.02 (-16.67%)
Updated
Jun 21 closing price
Capitalization
280.99M
SKYE
Price
$3.96
Change
-$0.26 (-6.16%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
130.75M
Interact to see
Advertisement

FGHQF vs SKYE

Header iconFGHQF vs SKYE Comparison
Open Charts FGHQF vs SKYEBanner chart's image
Frontage
Price$0.10
Change-$0.02 (-16.67%)
Volume$100K
Capitalization280.99M
Skye Bioscience
Price$3.96
Change-$0.26 (-6.16%)
Volume$2.27K
Capitalization130.75M
FGHQF vs SKYE Comparison Chart in %
Loading...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGHQF vs. SKYE commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHQF is a Buy and SKYE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (FGHQF: $0.10 vs. SKYE: $4.22)
Brand notoriety: FGHQF and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGHQF: 100% vs. SKYE: 47%
Market capitalization -- FGHQF: $280.99M vs. SKYE: $130.75M
FGHQF [@Biotechnology] is valued at $280.99M. SKYE’s [@Biotechnology] market capitalization is $130.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGHQF’s FA Score shows that 0 FA rating(s) are green whileSKYE’s FA Score has 0 green FA rating(s).

  • FGHQF’s FA Score: 0 green, 5 red.
  • SKYE’s FA Score: 0 green, 5 red.
According to our system of comparison, SKYE is a better buy in the long-term than FGHQF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SKYE’s TA Score shows that 4 TA indicator(s) are bullish.

  • SKYE’s TA Score: 4 bullish, 4 bearish.

Price Growth

FGHQF (@Biotechnology) experienced а 0.00% price change this week, while SKYE (@Biotechnology) price change was +1.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

SKYE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FGHQF($281M) has a higher market cap than SKYE($131M). FGHQF has higher P/E ratio than SKYE: FGHQF (34.83) vs SKYE (3.57). SKYE YTD gains are higher at: 39.223 vs. FGHQF (0.000).
FGHQFSKYEFGHQF / SKYE
Capitalization281M131M215%
EBITDAN/A-31.66M-
Gain YTD0.00039.223-
P/E Ratio34.833.57977%
RevenueN/A0-
Total CashN/A59.2M-
Total DebtN/A412K-
FUNDAMENTALS RATINGS
SKYE: Fundamental Ratings
SKYE
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGHQFSKYE
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
2%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
2%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIEZX13.59N/A
N/A
Fidelity Advisor Total Intl Equity Z
GSCLX30.32N/A
N/A
Goldman Sachs Large Cap Gr Insghts Svc
SGPIX108.93N/A
N/A
ProFunds Small Cap Growth Inv
CPTUX89.47N/A
N/A
Invesco Discovery Large Cap R5
MAIHX19.18N/A
N/A
Morgan Stanley Inst Passport ovrs eq IR

FGHQF and

Correlation & Price change

A.I.dvisor tells us that FGHQF and ANL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGHQF and ANL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
ANL - FGHQF
25%
Poorly correlated
-0.72%
SKYE - FGHQF
15%
Poorly correlated
-2.99%
LEXX - FGHQF
9%
Poorly correlated
+0.67%
HMTXF - FGHQF
8%
Poorly correlated
+4.40%
ZVRA - FGHQF
4%
Poorly correlated
+0.09%
More

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with CRBP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
-6.64%
CRBP - SKYE
45%
Loosely correlated
-0.12%
JANX - SKYE
40%
Loosely correlated
+0.47%
OVID - SKYE
34%
Loosely correlated
-4.21%
VKTX - SKYE
34%
Loosely correlated
+2.93%
ABOS - SKYE
32%
Poorly correlated
+4.00%
More